On March 20, 2017, the FDA approved the latest addition to the JUVEDERM® Injectable Gel family of soft tissue fillers for facial wrinkles and folds. Juvederm Vollure™ XC is a hyaluronic acid derivative, indicated for moderate to severe facial wrinkles and folds. It has the VYCROSS® technology found in Juvederm Voluma™ (indicated for cheek augmentation) and Juvederm Volbella™ (indicated for lip lines). Because of the blend of different molecular weights of hyaluronic acid bound together using the VYCROSS® technology, results with Juvederm Vollure™ XC were found to last up to 18 months in clinical studies, which is considerably longer than the 6-8 months usually found with Juvederm® Injectable Gel. Juvederm Vollure™ XC was first approved as Juvederm Volift™ in Europe in 2013, and has a 4 year track record of safety.
The physicians at Aesthetic Surgery Center, Dr. Agarwal, Dr. Maloney and Dr. Gill were chosen by Allergan to be part of the “Vollure Experience Program.” Because of their extensive experience with injectable fillers, our physicians are among the very first in southwest Florida to use long lasting Juvederm Vollure™ XC! A consultation with one of our board certified physicians is the best way to find out which combination of injectable fillers is right for you.
Related Procedures: BellaFill, BOTOX® Cosmetic, JUVÉDERM®, Juvederm Volbella® XC, Juvederm Voluma™ XC, Kybella Treatment, Perlane, Radiesse®, Restylane